Following the launch of multiple tumor diagnostic partnerships with Big Pharma earlier this year for its TruSight Oncology 500 assay, Illumina now aims to expand the use of its genomic profiling test ...
Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina's growing research and clinical ...
SAN DIEGO, July 25, 2023 /PRNewswire/ -- Illumina Inc. (ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today ...
GUILDFORD, SURREY / ACCESS Newswire / January 29, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback